Literature DB >> 15280626

A comparison of the sources of cancer mortality in China.

Ling Yang1, D Maxwell Parkin, Liandi Li, Yude Chen.   

Abstract

OBJECTIVE: To compare the validity of mortality data from available sources in China. MATERIALS,
METHODS: Two large-scale surveys have provided accurate national-level rates; the most recent involved deaths occurring in a random 10% sample of the population during 1990-1992. Since then, the only readily available sources are two on-going surveillance systems, which provide annual estimates of mortality--the "Disease Surveillance Points" (DSP) sample survey, and that established by the Center of Health Information and Statistics (CHIS) of the ministry of health, the results of which are published by WHO. They were compared with respect to the representativeness of the populations covered and the rates obtained.
RESULTS: Neither source covers a random sample of the Chinese population, with respect to age group, sex, and urban-rural residence, although the DSP population is the more representative of the national population in this respect. Sex and region (urban/rural) specific age-standardized mortality rates from the CHIS dataset were, however, closer to those from the (1990-1992) national survey, than those calculated from DSP data.
CONCLUSIONS: The CHIS data is the preferred source for estimation of national mortality, and study of time trends, but requires appropriate weighting (by age, sex, rural/urban residence). The within-stratum estimates are more stable than those of DSP, because of its larger sample size.

Entities:  

Mesh:

Year:  2004        PMID: 15280626     DOI: 10.1023/B:CACO.0000036181.37225.91

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  7 in total

1.  Direct in vivo injection of 131I-GMS and its distribution and excretion in rabbit.

Authors:  Yu Ma; Yi Wan; Dong-Hui Luo; Li-Geng Duan; Lin Li; Chuan-Qin Xia; Xiao-Li Chen
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

2.  [Estimates of lung cancer mortality at the province level in China].

Authors:  Yuanqiu Li; Min Dai; Yuanli Chen; Siwei Zhang; Wanqing Chen; Zhen Dai; Xiaonong Zou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-02

3.  Current status of gynecological cancer in China.

Authors:  Kidong Kim; Rongyu Zang; Seok-Cheol Choi; Sang-Young Ryu; Jae Weon Kim
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

4.  Temporal trend of mortality from major cancers in Xuanwei, China.

Authors:  Hualiang Lin; Bofu Ning; Jihua Li; Guangqiang Zhao; Yunchao Huang; Linwei Tian
Journal:  Front Med       Date:  2015-08-24       Impact factor: 4.592

5.  Mortality registration and surveillance in China: History, current situation and challenges.

Authors:  Gonghuan Yang; Jianping Hu; Ke Quin Rao; Jeimin Ma; Chalapati Rao; Alan D Lopez
Journal:  Popul Health Metr       Date:  2005-03-16

6.  Lung Cancer Mortality Trends in China from 1988 to 2013: New Challenges and Opportunities for the Government.

Authors:  Lijun Wang; Chuanhua Yu; Yu Liu; Jun Wang; Chunhui Li; Quan Wang; Peigang Wang; Shaotang Wu; Zhi-Jiang Zhang
Journal:  Int J Environ Res Public Health       Date:  2016-10-28       Impact factor: 3.390

7.  Estimation and projection of the national profile of cancer mortality in China: 1991-2005.

Authors:  L Yang; D M Parkin; L D Li; Y D Chen; F Bray
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.